Press Releases

MONROE TOWNSHIP, N.J., Dec. 2, 2019 /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world's leading companies in the diagnostic imaging business, announced today that its contrast agent LUMASON is the first ultrasound enhancing agent (UEA) to obtain U.S. Food and Drug Administration (FDA) approval for use in echocard

WOONSOCKET, R.I., Dec. 2, 2019 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 375 CVS Pharmacy locations in North Carolina, including pharmacies located in Target stores. The safes are anticipated to help prevent pha

BOTHELL, Wash., Dec. 2, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio

TUCSON, Ariz., Dec. 2, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) announced today that Louise Francesconi has been appointed to the company's Board of Directors.

TUCSON, Ariz., Dec. 2, 2019 /PRNewswire/ -- Mediaplanet's Fighting Alzheimer's campaign, an editorial dedicated to raising awareness surrounding multiple diseases and conditions, last week published a historical article titled "Why Preventing Alzheimer's Requires a Holistic Approach." ARPF commends Mediaplanet for openly stating that Alzheimer's

CHICAGO, Dec. 2, 2019 /PRNewswire/ -- Ikonopedia showcases enhancements to its breast biopsy reporting tool designed to improve efficiency and clinical utility, here, at the 105th Annual Radiological Society of North America (RSNA) meeting, December 1-6, 2019 (North Hall #6008). The latest breast

ATLANTA, Dec. 2, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-nside TAAA multibranch stent graft system for the endovascular treatment of thoraco-abdominal aneurysms. 

NASHVILLE, Tenn., Dec. 2, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for RediTrex™, its new line of methotrexate products.

BOTHELL, Wash., and TOKYO, Dec. 2, 2019 /PRNewswire/ -- Seattle Genetics, Inc. (Nasdaq:SGEN) and

MONMOUTH JUNCTION, N.J., Dec. 2, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its